Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Dipanjan Chowdhury

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5645-3752; OpenAlex author ID A5004787236; NIH RePORTER profile ID 9389403. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 grant

Papers 2

  1. 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer. Last author DOI 10.1038/s41467-024-50999-2↗
  2. Inhibition of non-homologous end joining repair impairs pancreatic cancer growth and enhances radiation response. Co-author DOI 10.1371/journal.pone.0039588↗

Grants 1

  1. TIRR/53BP1 complex regulates mitotic fidelity and immune-mediated radiation response R01CA301574↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alexander Spektor · 1 shared paper, 1 shared grant, 2024–2026 · strength 1.46
  2. Zuzanna Nowicka · 1 shared paper, 2024 · strength 0.20
  3. Wojciech M Fendler · 1 shared paper, 2024 · strength 0.20
  4. Yajie Sun · 1 shared paper, 2024 · strength 0.20
  5. Yinghua Li · 1 shared paper, 2012 · strength 0.04
  6. Alec C. Kimmelman · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.